TTrialPathMatch Me to Trials
← Back to trials
RecruitingAcute PorphyriasCutaneous Porphyrias

Longitudinal Study of the Porphyrias

Eligible age

All ages

Accepts

All genders

Locations

13 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The objective of this protocol is to conduct a longitudinal multidisciplinary investigation of the human porphyrias including the natural history, morbidity, pregnancy outcomes, and mortality in people with these disorders.

Sponsor: The American Porphyrias Expert Collaborative

You may qualify if…

  • Individuals with a documented diagnosis of a porphyria.
  • For each type of porphyria, the inclusion criteria are based on
  • Biochemical findings, as documented by laboratory reports (or copies) of porphyria-specific testing performed after 1980 (Absolute values are preferred for diagnostic biochemical thresholds. Fold increases in comparison to an upper (or lower) limit of normal (ULN or LLN) are also acceptable, but are complicated by considerable variation between laboratories in normal limits. Equivocal biochemical measurements may require confirmation by a consortium reference laboratory;)
  • molecular findings documenting the identification of a mutation in a porphyria-related gene.
  • In addition, an individual or a parent or guardian must be willing to give written informed consent or assent, as appropriate.
  • Provision is made for enrolling relatives who may not have symptoms but have biochemical or molecular documentation of a porphyria, or in the case of recessive disorders carry a disease-related mutation.

You may not qualify if…

  • Cases with elevations of porphyrins in urine, plasma or erythrocytes due to other diseases (i.e. secondary porphyrinuria or porphyrinemia), such as liver and bone marrow diseases;
  • Patients with a prior diagnosis of porphyria that cannot be documented by review of existing medical records or repeat biochemical or DNA testing.

Where it's recruiting

Alabama

Birmingham

California

Los Angeles · San Francisco

Florida

Miami

Illinois

Chicago

Minnesota

Minneapolis

New York

New York

North Carolina

Charlotte · Winston-Salem

Ohio

Cleveland

Pennsylvania

Philadelphia

Texas

Galveston · Houston

Utah

Salt Lake City

Source: ClinicalTrials.gov · NCT01561157 · last updated 2026-05-15